US Pharma MarketingThe post First patient dosed in Estrella’s STARLIGHT-1 Phase I/II trial appeared first on Clinical Trials Arena.
First patient dosed in Estrella’s STARLIGHT-1 Phase I/II trial
Estrella Immunopharma has dosed the first patient in the dose-expansion segment of its STARLIGHT-1 Phase I/II trial, assessing EB103 for r/r B-cell NHL. The post First patient dosed in Estrella’s STARLIGHT-1 Phase I/II trial appeared first on Clinical Trials Arena .
Estrella Immunopharma has dosed the first patient in the dose-expansion segment of its STARLIGHT-1 Phase I/II trial, assessing EB103 for r/r B-cell NHL.
Source: Clinical Trials Arena